مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

800
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

IN VITRO ANTIFUNGAL EFFECTS OF KETOCONAZOLE AGAINST CLINICAL ISOLATES OF CANDIDA FROM VULVOVAGINAL CANDIDIASIS

Pages

  71-78

Abstract

 Introduction: CANDIDA SPP. plays a major role in vulvovaginal infections. Vulvovaginal candidiasis is the second most common genital complaint in women. Around 5% of women, however, develop a chronic or recurrent form of vulvovaginal candidiasis resistant to antifungal treatment.Materials & Methods: In this study, in vitro activity of KETOCONAZOLE (KTZ) was investigated for 28 Candida strains isolated from patients with vulvovaginal candidiasis. BROTH DILUTION METHOD was used for determining the ANTIFUNGAL ACTIVITY of KETOCONAZOLE. The fungi were cultured on sabouraud dextrose broth in presence of various concentrations of KETOCONAZOLE and the minimal inhibitory concentrations (MICS) of KTZ were determined.Results: MICS of KTZ were measured in the range of 0.1-570 (µg/ml) for C. albicans isolates, 0.1-570 (µg/ml) for C. glabrata isolates, 0.1-280 (µg/ml) for C. tropicalis isolates and 0.1 – 30 (µg/ml) for C. kefyr, respectively. Conclusion: On the basis of the obtained results, evaluation of antifungal susceptibility for clinical Candida isolates before selection of antifungal drugs and onset of treatment is essential because of the differences observed in species and strain level. This may lead to better treatment and prevention by creating drug-resistant isolates which are non-responsive to routine antifungals.

Cites

  • No record.
  • References

    Cite

    APA: Copy

    MOGHADASI, B., SHAMS GHAHFAROKHI, M., ZEYNI, F., & RAZAGHI ABYANEH, M.. (2009). IN VITRO ANTIFUNGAL EFFECTS OF KETOCONAZOLE AGAINST CLINICAL ISOLATES OF CANDIDA FROM VULVOVAGINAL CANDIDIASIS. DANESHVAR MEDICINE, 16(78), 71-78. SID. https://sid.ir/paper/30529/en

    Vancouver: Copy

    MOGHADASI B., SHAMS GHAHFAROKHI M., ZEYNI F., RAZAGHI ABYANEH M.. IN VITRO ANTIFUNGAL EFFECTS OF KETOCONAZOLE AGAINST CLINICAL ISOLATES OF CANDIDA FROM VULVOVAGINAL CANDIDIASIS. DANESHVAR MEDICINE[Internet]. 2009;16(78):71-78. Available from: https://sid.ir/paper/30529/en

    IEEE: Copy

    B. MOGHADASI, M. SHAMS GHAHFAROKHI, F. ZEYNI, and M. RAZAGHI ABYANEH, “IN VITRO ANTIFUNGAL EFFECTS OF KETOCONAZOLE AGAINST CLINICAL ISOLATES OF CANDIDA FROM VULVOVAGINAL CANDIDIASIS,” DANESHVAR MEDICINE, vol. 16, no. 78, pp. 71–78, 2009, [Online]. Available: https://sid.ir/paper/30529/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button